Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Wagner

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Autoimmunity|October 28, 2008
CD40 on NOD CD4 T cells contributes to their activation and pathogenicityRocky L Baker, David H Wagner, Kathryn Haskins
Journal of Neuroimmunology|March 30, 2019
A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitisGisela M Vaitaitis, Martin G Yussman, David H Wagner
European Journal of Immunology|April 29, 2004
Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitusDan M Waid, Gisela M Vaitaitis, David H Wagner
European Journal of Immunology|November 23, 2011
CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts toleranceJessica Carter, Gisela M Vaitaitis, Dan M Waid, et al.
Microbial Pathogenesis|August 28, 2023
Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibitionFernanda M Frank, David H Wagner, Miriam Postan, et al.
Journal of Leukocyte Biology|May 13, 2008
Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetesDan M Waid, Gisela M Vaitaitis, Nathan D Pennock, et al.
Immunology|May 26, 2017
CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetesGisela M Vaitaitis, Dan M Waid, Martin G Yussman, et al.
Plos One|February 14, 2017
Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cellsGisela M Vaitaitis, Martin G Yussman, Dan M Waid, et al.
Journal of Neuroimmunology|December 19, 2022
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)Christian Curran, Gisela Vaitaitis, Dan Waid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the peripheryGisela M Vaitaitis, Michelle Poulin, Richard J Sanderson, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Autoimmunity|October 28, 2008
CD40 on NOD CD4 T cells contributes to their activation and pathogenicityRocky L Baker, David H Wagner, Kathryn Haskins
Journal of Neuroimmunology|March 30, 2019
A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitisGisela M Vaitaitis, Martin G Yussman, David H Wagner
European Journal of Immunology|April 29, 2004
Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitusDan M Waid, Gisela M Vaitaitis, David H Wagner
European Journal of Immunology|November 23, 2011
CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts toleranceJessica Carter, Gisela M Vaitaitis, Dan M Waid, et al.
Microbial Pathogenesis|August 28, 2023
Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibitionFernanda M Frank, David H Wagner, Miriam Postan, et al.
Journal of Leukocyte Biology|May 13, 2008
Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetesDan M Waid, Gisela M Vaitaitis, Nathan D Pennock, et al.
Immunology|May 26, 2017
CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetesGisela M Vaitaitis, Dan M Waid, Martin G Yussman, et al.
Plos One|February 14, 2017
Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cellsGisela M Vaitaitis, Martin G Yussman, Dan M Waid, et al.
Journal of Neuroimmunology|December 19, 2022
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)Christian Curran, Gisela Vaitaitis, Dan Waid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the peripheryGisela M Vaitaitis, Michelle Poulin, Richard J Sanderson, et al.
Pageof 4